News

Identifiquen un nou biomarcador que podria ajudar a determinar el risc de mortalitat en un subgrup de pacients amb sèpsia

Un estudi liderat pel Dr. Jaume Baldirà, investigador del Grup de Recerca en Medicina Intensiva de l’Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau – IIB Sant Pau i metge adjunt ...

Dr. Alba Tristán Noguero receives the prestigious “EMBO Scientific Exchange Grant”

Dr. Alba Tristán Noguero, postdoctoral researcher of the 'Margarita Salas' Program at the Department of Genetics, Microbiology, and Statistics of the Faculty of Biology at the University of Barcelona...

PHOTO OF THE MONTH: Macrophage Characterization in Muscle Biopsies by Andrea Bravo

[caption id="attachment_42794" align="aligncenter" width="4175"] Double immunofluorescence with CD206 and CD68. The immunostaining shows CD206+ macrophages (green), CD68+ macrophages (red), and coloca...

A combination therapy, new option for patients with advanced urothelial cancer who cannot receive conventional chemotherapy

Patients with locally advanced or metastatic urothelial cancer who are unable to receive cisplatin chemotherapy, which is the conventional first-line treatment for this disease, face very limited opti...

Un estudi amb participació de l’IIB Sant Pau guanya el XXIV Premi Dr. Lino Torre

Un estudi multicèntric en què han participat, investigadors del Grup de Cirurgia General i Digestiva de l'Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau – IIB Sant Pau, que dirigeix...